PLK4 and breast carcinoma: PLK4 inhibition by CFI-400945 in breast cancer in vivo and in vitro TNBC models has been shown to augment and synergize the effects of radiation treatment [103, 115], through mechanisms that potentially involve overamplification of centrioles [103] and alterations in DNA damage response and cell cycle regulation [138].